Acadian Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,744
Closed -$274K 2235
2024
Q3
$274K Buy
+4,744
New +$233K ﹤0.01% 1262
2021
Q3
Sell
-27,025
Closed -$1.7M 2061
2021
Q2
$1.7M Buy
27,025
+25,292
+1,459% +$935K 0.01% 762
2021
Q1
$47K Buy
+1,733
New +$41.7K ﹤0.01% 1841

Other funds holding ASTH

Acadian Asset Management's ASTH Position: Q4 2024 in Review

Acadian Asset Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 4,744 shares — an estimated $274K sold.

Acadian Asset Management first reported a position in ASTH in Q1 2021 and held it in 3 quarters. The position peaked at $1.7M in Q2 2021. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Acadian Asset Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 4,744 Astrana Health shares in Q4 2024, an estimated $274K.
  • Acadian Asset Management first reported a position in Astrana Health in Q1 2021 and held it in 3 quarters.
  • Acadian Asset Management's Astrana Health position peaked at $1.7M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.